Vertex Pharmaceuticals is laying off workers and consolidating its real estate footprint in Rhode Island after ending a ...

NBC Securities recently dipped its toe into the biotech pool by purchasing 345 shares of Vertex Pharmaceuticals, valued at $167,000. Several other institutional investors followed suit, tweaking their ...

Vertex Pharmaceuticals continues to dominate biotech with its cystic fibrosis breakthroughs and pioneering gene-editing and ...

As a company, Vertex says, “We strike at the core of serious diseases to change people’s lives. Bringing together the ...